ghk-cu reduces inflammation Topical Spray Copper Peptide Before and After:

Among the research peptides receiving increasing attention is the BPC 157 TB 500 blend, a combination frequently selected for experimental studies involving multiple biological pathways

Everything this article covers comes from lab and animal data, and that distinction matters throughout

Diabetic Neuropathy: A Position Statement by the American Diabetes Association

The importance of slow-wave sleep for physical recovery The delta phase is the moment when brain activity slows down to its lowest level, and the body enters an intensive biological renewal mode

But as I AM always telling people, absence of human trial data is not evidence of danger and conflating the two is intellectually dishonest

(2015) described the development of angiotensin IV analogs including Dihexa and their HGF/c-Met potentiation mechanism (PMID: 25455861) Expression of Concern: The landmark 2012 paper describing Dihexa's cognitive effects received an expression of concern from the journal (PMID: 34551989), citing data integrity issues including questioned Western blot images Retraction: A follow-up paper from the same research group was retracted (PMID: 40312093), further undermining the evidence base for Dihexa's reported effects No Human Studies: No clinical trials, pharmacokinetic studies, or safety assessments have been conducted in humans Limited Independent Replication: The core claims about Dihexa's cognitive-enhancing effects have not been independently replicated by groups outside the original laboratory The Evidence Gap: This comparison starkly illustrates the difference between a compound with decades of clinical validation (Cerebrolysin) and one with provocative preclinical data undermined by integrity concerns (Dihexa)